ImmunityBio

ImmunityBio is a clinical-stage immunotherapy biotech based in California.

ImmunityBio responds to FDA warning letter with new protocols

ImmunityBio's new protocols aim to ensure that promotional communications are “accurate, balanced and compliant with FDA regulations," the company said.

Kevin Dunleavy Apr 6, 2026 3:10pm

ImmunityBio hit with FDA warning letter over Anktiva promotions

Mar 24, 2026 1:15pm

FDA chides BeOne, ImmunityBio in separate untitled letters

Jan 15, 2026 11:50am

On target clinical trial success bullseye score

ImmunityBio's Anktiva hits the mark in bladder cancer subtype

Dec 17, 2025 9:35am

Traffic light go start restart green light

GSK's long-acting asthma med wins CHMP backing

Dec 12, 2025 11:27am

Close up of horse legs and hooves running on sand track

J&J puts ImmunityBio on defense mode in bladder cancer

Apr 27, 2025 12:35pm